Balter Liquid Alternatives’s Pfizer PFE Stock Holding History

Balter Liquid Alternatives’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16,864	Closed	-$11K	–	56
2016 Q1	$11K	Buy	+16,864	New	+$482K	0.03%	47

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balter Liquid Alternatives's PFE Position: Q2 2017 in Review

Balter Liquid Alternatives sold out of Pfizer (PFE) in Q2 2017, closing a stake of 7,502 shares — an estimated $244K sold.

Balter Liquid Alternatives first reported a position in PFE in Q1 2016 and held it in 5 quarters. The position peaked at $683K in Q2 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Balter Liquid Alternatives reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Balter Liquid Alternatives sold 7,502 Pfizer shares in Q2 2017, an estimated $244K.
Balter Liquid Alternatives first reported a position in Pfizer in Q1 2016 and held it in 5 quarters.
Balter Liquid Alternatives's Pfizer position peaked at $683K in Q2 2016.
2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Balter Liquid Alternatives's 13F filing for Q2 2017, filed 7 Aug 2017.